Literature DB >> 21442385

Pharmacy and therapeutics committees: leadership opportunities in medication safety for medical toxicologists.

Jeanmarie Perrone, Lewis S Nelson.   

Abstract

Mesh：

Year:  2011        PMID： 21442385      PMCID： PMC3724438          DOI： 10.1007/s13181-011-0147-5

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  14 in total

1.  Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.

Authors:  Peter Lurie; Cristina M Almeida; Nicholas Stine; Alexander R Stine; Sidney M Wolfe
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Peer-reviewed publication of clinical trials completed for pediatric exclusivity.

Authors:  Daniel K Benjamin; Philip Brian Smith; M Dianne Murphy; Rosemary Roberts; Lisa Mathis; Debbie Avant; Robert M Califf; Jennifer S Li
Journal:  JAMA       Date:  2006-09-13       Impact factor: 56.272

Review 3.  Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.

Authors:  Curtis Wright; Sidney Schnoll; David Bernstein
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  President Obama's health care reform policies: Issues of interest to P&T committees.

Authors:  C Lee Ventola
Journal:  P T       Date:  2009-06

5.  Everyone's a little bit biased (even physicians).

Authors:  Daylian M Cain; Allan S Detsky
Journal:  JAMA       Date:  2008-06-25       Impact factor: 56.272

6.  ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.

Authors:  Linda S Tyler; Sabrina W Cole; J Russell May; Mirta Millares; Michael A Valentino; Lee C Vermeulen; Andrew L Wilson
Journal:  Am J Health Syst Pharm       Date:  2008-07-01       Impact factor: 2.637

7.  How many "me-too" drugs is too many?

Authors:  Joshua J Gagne; Niteesh K Choudhry
Journal:  JAMA       Date:  2011-02-16       Impact factor: 56.272

8.  Conflicts of interest on pharmacy and therapeutics committees at academic medical centers.

Authors:  Brenna M Farmer; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2011-06

9.  Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians.

Authors:  Gabriel K Silverman; George F Loewenstein; Britta L Anderson; Peter A Ubel; Stanley Zinberg; Jay Schulkin
Journal:  J Med Ethics       Date:  2010-05       Impact factor: 2.903

10.  Off-label prescribing of drugs for children.

Authors:  Albert Wertheimer
Journal:  Curr Drug Saf       Date:  2011-02-01
View more
  3 in total

1.  Position statement: medical toxicologist participation in medication management and safety systems.

Authors: 
Journal:  J Med Toxicol       Date:  2015-03

2.  A P&T Committee's Transition to a Complete Electronic Meeting System-A Multisite Institution Experience.

Authors:  Ahmed H Al-Jedai; Roaa A Algain; Said A Alghamidi; Abdulrazaq S Al-Jazairi; Rashid Amin; Ibrahim Z Bin Hussain
Journal:  P T       Date:  2017-10

3.  Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures.

Authors:  Qais Alefan; Somayya Alshareef; Samah Al-Shatnawi
Journal:  Pharm Pract (Granada)       Date:  2019-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.